Navigation Links
Driven by Sales of Lyrica, Cymbalta/Xeristar and Savella, the Fibromyalgia Drug Market Will Experience 4.2 Percent Annual Growth Through 2018
Date:9/8/2010

BURLINGTON, Mass., Sept. 8 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that increasing use of U.S. regulatory-approved agents -- Pfizer's Lyrica (pregabalin), Eli Lilly/Boehringer Ingelheim's Cymbalta/Xeristar (duloxetine) and Forest Laboratories' Savella (milnacipran) -- will drive 4.2 percent annual growth in the fibromyalgia drug market from 2009 to 2018. However, owing to the generic entry of sales-leading pregabalin, the market will decline sharply from $1.8 billion in 2018 to only $1.4 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

The Pharmacor 2010 findings from the topic entitled Fibromyalgia reveal that an expanding drug-treated population, resulting from increasing diagnosis rates, will fuel annual market growth over the next several years in the world's major pharmaceutical markets. While the United States will account for more than two-thirds of major-market fibromyalgia drug sales in 2019, market expansion in Europe and Japan will be constrained by a dearth of approved therapies, lower diagnosis rates and less widespread recognition of the disorder.

The findings also reveal that duloxetine is now in close competition with pregabalin for market-leading status in the United States.

"Although pregabalin was the U.S. patient- and market-share leader in 2009, patient share of duloxetine grew significantly last year," said Decision Resources Analyst Andrea Buurma. "Sales of duloxetine are not projected to surpass pregabalin sales during our forecast period, owing in large part to market entry of generic duloxetine in the United States in 2013; however, we do expect duloxetine to supplant pregabalin as the U.S. patient-share leader by 2015."

The Pharmacor 2010 findings also reveal that, in light of the recent recommendation by an FDA advisory committee ag
'/>"/>

SOURCE Decision Resources, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Increasing Potential for RIS-driven PACS Modules in Europe, Finds Frost & Sullivan
2. New Study Shows Meganuclease-Driven Targeted Integration Using Cellectis bioresearchs cGPS® CHO-K1 Kit to be Highly Efficient for Drug Discovery
3. GeneGo Releases Content and Tools From Industry-FDA Driven MetaTox Partnership Via ToxHunter(TM)
4. Energetiq Introduces Laser-Driven Light Sources for Biophysical Applications
5. The Cancer Pain Drug Market, Driven by the Continued Dominance of Opioids, Will Increase From $2.3 Billion in 2008 to $3.7 Billion in 2018
6. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
7. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
8. Reportlinker Adds Pharmaceutical Contract Sales Organizations (CSO) - Emerging Markets to Drive Growth but Talent Acquisition in Specialty Secondary Care Remains a Challenge
9. SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products
10. Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010
11. Kewaunee Scientific Reports Sales and Earnings for First Quarter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 /PRNewswire-iReach/ -- In a ... bridge the gap between the electronic medical record ... links, readers can experience, first-hand, how seamless integration ... Photo - http://photos.prnewswire.com/prnh/20140827/140443 ... access to imaging from within the patient record ...
(Date:8/27/2014)... CITY , Aug. 27, 2014 Varian Medical ... expand its current Salt Lake City ... underway outside of Utah to ultimately ... the next 20 years. " Utah ... and technical talent, many of whom can be credited with ...
(Date:8/27/2014)... Aug. 27, 2014 By now, if you haven,t ... living on this planet. The awareness campaign has brought this ... helped to raise over $88.5 Million (and counting) for ALS. ... some companies are starting to as well. One ... Florida , who actually works with ALS sufferers and ...
Breaking Medicine Technology:DICOM Grid Launches Interactive Guide to Demonstrate Image-Enabling the EMR 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 4Acorn Stairlifts Gives a Lift to the ALS Ice Bucket Challenge 2
... Pa., Sept. 18 ,Interleukin Genetics, Inc. (Amex: ... research collaboration to explore the role of genetics ... develop a series of genetic,tests that will help ... loss and, more specifically, gauge a patient,s,likelihood of ...
... Assess Effectiveness of Cladribine Tablets, in Preventing Conversion to Definite Multiple Sclerosis in Addition ... Fully Enrolled Phase III Pivotal Trial - ... - the CLARITY Study - ... GENEVA, Sept. 18 Merck Serono, a division of Merck,KGaA, Darmstadt, Germany, announced today ...
Cached Medicine Technology:Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success 2Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success 3Merck Serono Announces Initiation of the ORACLE MS Trial to Evaluate Cladribine Tablets in Patients at Risk of Developing Multiple Sclerosis 2Merck Serono Announces Initiation of the ORACLE MS Trial to Evaluate Cladribine Tablets in Patients at Risk of Developing Multiple Sclerosis 3Merck Serono Announces Initiation of the ORACLE MS Trial to Evaluate Cladribine Tablets in Patients at Risk of Developing Multiple Sclerosis 4Merck Serono Announces Initiation of the ORACLE MS Trial to Evaluate Cladribine Tablets in Patients at Risk of Developing Multiple Sclerosis 5
(Date:8/28/2014)... August 28, 2014 Coveros, Inc., ... announced that it has partnered with InfoZen on ... performance start date of 2/4/2014 with U.S. Citizenship ... Security (DHS) agency that oversees lawful immigration to ... and InfoZen will automate the integration and delivery ...
(Date:8/28/2014)... UniVoIP, Inc, a managed telephony ... announced that they have been certified with the state ... Small Business Enterprise (Local SBE) Preference Programs. “We are ... state of California and LA county and excited to ... to governmental agencies throughout the state,“ says Chris ...
(Date:8/27/2014)... 2014 A St. Louis law firm ... reports that the C.R. Bard multidistrict litigation (MDL), ... transvaginal mesh lawsuits, recently filed a new pretrial order ... the pretrial discovery process, and more specifically to the ... Carey Danis & Lowe is a law firm practicing ...
(Date:8/27/2014)... Recently, BambooIndustry.com, an innovative company that provides many kinds ... bamboo panels are now offered on its website. In ... worldwide. All people that place an order for its newly ... 30 percent off. , The company’s senior spokesman was ... all our new and old customers can buy cheap bamboo ...
(Date:8/27/2014)... August 28, 2014 Women’s Prosperity Network ... of As Seen On TV, Inc., and NY Times ... Maker”. as Excelerate attendees will learn how to pitch ... the ability to pitch to an investor panel. , ... Experts and Millionaire Mentors directly to attendees. , ...
Breaking Medicine News(10 mins):Health News:Coveros Partners with InfoZen on USCIS Transformation Integration Award 2Health News:Cloud PBX Provider UniVoIP Gets Certified by the State of California and the County of Los Angeles Under the Local Small Business Enterprise (SBE) Preference Program 2Health News:Carey Danis & Lowe Reports On New Court Order in C.R. Bard Transvaginal Mesh MDL 2Health News:BambooIndustry.com: Cheap Bamboo Panels for Clients Worldwide Offered Online 2
... Staffing Software introduces new features that quicken the recruitment process by ... across the web. , ... High Point, NC (Vocus) ... announced its first independently developed app called Capture Healthcare Job ...
... and Translation Firm Maintains WBENC Certification. , ... ... LLE®, a leading provider of foreign language interpretation, translation and ... the world, has received its renewed certification as a Women’s ...
... version 2.0 service: an innovative medical news search engine and ... medical sources is found. Excellent new tool for medical specialists, doctors ... ... 23, 2009 -- Newsguard today launched its rebranded version 2.0 service: ...
... England, April 23 We are all living,in stressful, uncertain times, but it ... stress and that is to produce stress hormones. This,is true whether: , , ... man with an axe, - You owe the bank GBP750,000 ... about to go out in front of an audience of, ...
... ON HEALTH REFORM, INCLUDING PUBLIC PLAN AND SOME TAX ... Will Hinge on Actual DebateMENLO PARK, Calif., April 23 ... the public continues to say that they or a ... care in the past year, according to the Kaiser ...
... for EvistaINDIANAPOLIS, April 22 Eli Lilly and Company ... District Court for the Southern District of Indiana today ... a generic version of Lilly,s medicine Evista(R) (raloxifene HCl ... final ruling. Teva had indicated it was prepared to ...
Cached Medicine News:Health News:BlueSky Medical Staffing Software Launches First Job Aggregation Engine App and Releases API for Developers 2Health News:BlueSky Medical Staffing Software Launches First Job Aggregation Engine App and Releases API for Developers 3Health News:LLE Receives Renewal of Women's Business Enterprise National Council Certification 2Health News:Innovative Search Engine for Medical News, Newsguard 2.0, Launched 2Health News:Stress and its Remedies 2Health News:Stress and its Remedies 3Health News:Six in Ten Say Family Put Off Medical Care Due to Cost 2Health News:Six in Ten Say Family Put Off Medical Care Due to Cost 3Health News:Six in Ten Say Family Put Off Medical Care Due to Cost 4Health News:Six in Ten Say Family Put Off Medical Care Due to Cost 5Health News:Six in Ten Say Family Put Off Medical Care Due to Cost 6Health News:Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene 2Health News:Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene 3
Black multi-pinhole occluder...
9 inch double ended with one end black and the other end with 49 holes...
Double Ended Occluders...
49 pinholes, black...
Medicine Products: